Subscribe

MiniMed Group, Inc. Common Stock (MMED)

USD15.78 +0.74 (+4.90%)
US NASDAQ Healthcare Medical - Care Facilities
Address 18000 Devonshire Street 91325
Northridge, CA, US
CEO Que Thanh Dallara
IPO 2026-03-05
ISIN US60365F1093

Explore sections of this company profile

Description

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD15.78 +0.74 (+4.90%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
947.9K
Beta
-3.63
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Valuation data will be available after the next weekly refresh.
Consensus Estimates
Metric Apr 2025
actual
Apr 2026
6 Rev. Ana.
3 EPS Ana.
Apr 2027
9 Rev. Ana.
6 EPS Ana.
Apr 2028
9 Rev. Ana.
6 EPS Ana.
Apr 2029
6 Rev. Ana.
3 EPS Ana.
Apr 2030
3 Rev. Ana.
1 EPS Ana.
Apr 2031
3 Rev. Ana.
1 EPS Ana.
Revenue
2.72B
est: 2.89B (-5.9%)
3.09B
3.08B – 3.10B
+7.0% YoY
3.42B
3.41B – 3.45B
+10.9% YoY
3.70B
3.66B – 3.74B
+8.0% YoY
4.06B
4.06B – 4.06B
+9.9% YoY
4.54B
4.51B – 4.57B
+11.6% YoY
4.96B
4.93B – 4.99B
+9.3% YoY
EBITDA
107.00M
est: 69.61M (+53.7%)
74.47M
74.23M – 74.71M
+7.0% YoY
82.57M
82.33M – 83.16M
+10.9% YoY
89.21M
88.25M – 90.17M
+8.0% YoY
98.03M
98.03M – 98.03M
+9.9% YoY
109.43M
108.72M – 110.21M
+11.6% YoY
119.61M
118.83M – 120.46M
+9.3% YoY
EBIT
-36.00M
est: -43.05M (+16.4%)
-46.06M
-46.21M – -45.91M
-7.0% YoY
-51.07M
-51.43M – -50.92M
-10.9% YoY
-55.17M
-55.77M – -54.58M
-8.0% YoY
-60.63M
-60.63M – -60.63M
-9.9% YoY
-67.68M
-68.16M – -67.24M
-11.6% YoY
-73.97M
-74.50M – -73.50M
-9.3% YoY
Net Income
-250.00M
87.67M
61.37M – 113.97M
172.07M
150.62M – 190.79M
+96.3% YoY
167.46M
115.56M – 198.46M
-2.7% YoY
437.27M
394.95M – 479.59M
+161.1% YoY
595.80M
590.79M – 601.33M
+36.3% YoY
808.29M
801.49M – 815.78M
+35.7% YoY
SGA
1.13B
est: 1.19B (-5.2%)
1.28B
1.27B – 1.28B
+7.0% YoY
1.42B
1.41B – 1.43B
+10.9% YoY
1.53B
1.51B – 1.55B
+8.0% YoY
1.68B
1.68B – 1.68B
+9.9% YoY
1.88B
1.86B – 1.89B
+11.6% YoY
2.05B
2.04B – 2.06B
+9.3% YoY
EPS
-0.89
0.33
0.24 – 0.44
0.68
0.59 – 0.74
+104.4% YoY
0.66
0.45 – 0.77
-2.8% YoY
1.75
1.54 – 1.87
+166.1% YoY
2.32
2.30 – 2.34
+33.1% YoY
3.15
3.12 – 3.18
+35.7% YoY

Owner Earnings

Owner's Earnings (history)

Owner's Earnings history not available.

Owner alignment
Owner's Earnings TTM
OE per share TTM
Owner's Yield
Maintenance CapEx ratio
Maint CapEx / Avg PPE

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 33 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Ballast Small/Mid Cap ETF MGMT 1.49% 2.24M 1.10%
2 First Trust US Equity Opportunities ETF FPX 0.35% 5.53M 0.57%
3 Goldman Sachs Innovate Equity ETF GINN 0.16% 343.9K 0.50%
4 First Trust US Equity Opportunities UCITS ETF FPX.L 0.09% 16.4K 0.65%
5 iShares Russell 2000 Value ETF IWN 0.03% 4.06M 0.24%
6 Franklin U.S. Small Cap Multifactor Index ETF FLQS 0.03% 14.1K 0.35%
7 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC 0.02% 221.2K 0.20%
8 Invesco Russell 2000 Dynamic Multifactor ETF OMFS 0.02% 56.8K 0.39%
9 State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L 0.02% 899.9K 0.30%
10 iShares Russell 2000 BuyWrite ETF IWMW 0.01% 8.0K 0.39%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Management data is not available for this company yet.
ESG Score History

No data available for this company.

Company data will be available after the next weekly refresh.
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits